Market Value2,675,754,000
Total Holdings72
File Date2021-08-16
Original Filing (Click here)

All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings. These reports are called 13F reports. However, the filings are required the following quarter from the reporting period, which means that by the time the filing is made (and we see them), the information could be five months old.

For funds with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover, the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions are identified in the table. However, they are not required to report short positions.

Click the link icon to see the full transaction history.

Upgrade to unlock premium data and export to Excel .

Security Imputed
Share Price
Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
(USD x1000)
Current Value
(USD x1000)
Change
(Percent)
FLACU / Frazier Lifesciences Acquisition Corp - Units (1 Ord Share Class A & 1/3 War)
LSAQ / LifeSci Acquisition II Corp
FRAZIER LIFESCIENCES ACQU CO / *W EXP 11/30/202 (G3710A113)
KYG9127T1242 / WARRANTS
G2445M111 / Consonance-HFW Acquisition Corp. Warrants, each whole warrant exercisable for one Class A Ordinary S
PRDS / Pardes Biosciences Inc
TBIO / Telesis Bio, Inc.
ARYD / ARYA Sciences Acquisition Corp IV
VGG3141W1225 / Eucrates Biomedical Acquisition Corp.
SRZN / Surrozen, Inc.
PRTA / Prothena Corporation plc
LOGC / ContextLogic Holdings Inc.
/ Pebblebrook Hotel Trust
MORF / Morphic Holding, Inc.
BOLT / Bolt Biotherapeutics, Inc.
HSAQ / Health Sciences Acquisitions Corp 2
FSTX / F-star Therapeutics Inc
US92731L1145 / Vincerx Pharma, Inc.
PRTA / Prothena Corporation plc Call
CRVS / Corvus Pharmaceuticals, Inc.
SBTX / Silverback Therapeutics Inc
KDNY / Chinook Therapeutics Inc
KURA / Kura Oncology, Inc.
AKUS / Akouos Inc
MGTX / MeiraGTx Holdings plc
ODT / Odonate Therapeutics Inc
MTCR / Metacrine Inc
FMTX / Forma Therapeutics Holdings Inc
ELDN / Eledon Pharmaceuticals, Inc.
SLDB / Solid Biosciences Inc.
RCUS / Arcus Biosciences, Inc.
TMPM / Turmeric Acquisition Corp - Class A
CDAK / Codiak Biosciences Inc
ALPN / Alpine Immune Sciences, Inc.
SYRS / Syros Pharmaceuticals, Inc.
JYAC / Jiya Acquisition Corp - Class A
BLSA / BCLS Acquisition Corp - Class A
KNTE / Kinnate Biopharma Inc.
FVAM / 5:01 Acquisition Corp.
FLAC / Frazier Lifesciences Acquisition Corp - Class A
MGTA / Magenta Therapeutics Inc
CNTA / Centessa Pharmaceuticals plc - Depositary Receipt (Common Stock)
BCEL / Atreca, Inc.
NRIX / Nurix Therapeutics, Inc.
IGMS / IGM Biosciences, Inc.
AMTI / Applied Molecular Transport Inc.
OMEG / Omega Alpha SPAC - Class A
EUCR / Eucrates Biomedical Acquisition Corp
ZNTL / Zentalis Pharmaceuticals, Inc.
HLXA / Helix Acquisition Corp - Class A
RPTX / Repare Therapeutics Inc.
CCCC / C4 Therapeutics, Inc.
NLTX / Neoleukin Therapeutics, Inc.
KRON / Kronos Bio, Inc.
BCAB / BioAtla, Inc.
AADI / Aadi Bioscience, Inc.
OVID / Ovid Therapeutics Inc.
ALEC / Alector, Inc.
CYCN / Cyclerion Therapeutics, Inc.
NGM / NGM Biopharmaceuticals, Inc.
KYMR / Kymera Therapeutics, Inc.
ACIU / AC Immune SA
PMVP / PMV Pharmaceuticals, Inc.
VERV / Verve Therapeutics, Inc.
NUVB.WS / Panacea Acquisition Corp. - Equity Warrant
CMAXW / CareMax Inc - Warrants (08/06/2026)
ITOS / iTeos Therapeutics, Inc.
DSGN / Design Therapeutics, Inc.
DYN / Dyne Therapeutics, Inc.
TNGX / Tango Therapeutics, Inc.
XNCR / Xencor, Inc.
MRTX / Mirati Therapeutics, Inc.
GRTS / Gritstone bio, Inc.
RNA / Avidity Biosciences, Inc.
RLAY / Relay Therapeutics, Inc.
ORIC / ORIC Pharmaceuticals, Inc.
EWTX / Edgewise Therapeutics, Inc.
ARVN / Arvinas, Inc.
ALVR / AlloVir, Inc.
NUVB / Nuvation Bio Inc.
ANAB / AnaptysBio, Inc.
JANX / Janux Therapeutics, Inc.
STTK / Shattuck Labs, Inc.